Rakovina Therapeutics Announces 2024 Q2 Financial Results and Provides Corporate Update
All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Rakovina...
Clinical Trial
IO Biotech Updates on Pivotal Phase 3 Trial of IO102-IO103 in Combination with KEYTRUDA® (pembrolizumab) as a First-Line Treatment for Patients with Advanced Melanoma
- Based on a per-protocol interim analysis of safety and efficacy data, the Independent Data Monitoring Committee (IDMC) recommended that...
Grit Biotechnology Receives U.S. FDA Clearance of Investigational New Drug Application for GT201, a genetically engineered TIL, following its Chinese IND Approval
SHANGHAI, Aug. 30, 2024 /PRNewswire/ -- Grit Biotechnology, a leading clinical-stage cell therapy company focusing on tumor-infiltrating lymphocyte (TIL) therapies, has...
Quantum Biopharma Announces Celly Nutrition Launches unbuzzd(TM) Grab-and-Go Stick Packs on Amazon.com so you can “own NOW and what’s NEXT”
TORONTO, ON / ACCESSWIRE / August 30, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical...
Celly Nutrition Launches unbuzzd Grab-and-Go Stick Packs on Amazon.com so You Can “Own Now and What’s Next”
Vancouver, British Columbia--(Newsfile Corp. - August 29, 2024) - Celly Nutrition Corp. ("Celly Nutrition" or the "Company") proudly announces the...
Zomedica’s Assisi Loop(R) Product Line Designated as Fear Free(TM) Preferred Product
Assisi’s tPEMF™ technology aligns with Fear Free’s mission to “prevent and alleviate fear, anxiety, and stress in pets” ANN ARBOR, MI...
The International Myeloma Foundation (IMF) Brings Back ‘Do You #kNOwMyeloma?’ for Blood Cancer Awareness Month 2024
LOS ANGELES, Aug. 29, 2024 (GLOBE NEWSWIRE) -- With Blood Cancer Awareness Month coming up this September, the International Myeloma...
Femasys Announces CE Mark and Canadian Approval for FemVue® MINI, a Fallopian Tube Assessment Solution
ATLANTA, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing significant unmet needs...
Safety Shot Clinical Data Results Confirm Breakthrough in Dramatic Reduction of Morning-After Symptoms Associated with Excessive Drinking
The Company Showed a Substantial Reduction in the Physical, Negative Characteristics that Accompany Heavy Drinking in its Recent Groundbreaking, Clinical...
Can-Fite Reports First Half 2024 Financial Results & Progress in Two Pivotal Phase III Clinical Studies
RAMAT GAN, Israel, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company...
ORYZON to Provide Corporate Progress Updates at Several Events in September
German Fall Conference 2024European College of Neuropsychopharmacology (ECNP) congress 2024Sachs Annual Biotech in Europe Forum 2024 MADRID, Spain and CAMBRIDGE,...
Safety Shot Announces Partnership with Digital Growth Platform VENDO
As Masters in the E-Commerce Space VENDO is Anticipated to Significantly Help to Grow the Safety Shot Brand Online. JUPITER,...
Veeva Announces Fiscal 2025 Second Quarter Results
Total Revenues of $676.2M, up 15% Year Over Year;Subscription Services Revenues of $561.3M, up 19% Year Over Year PLEASANTON, Calif.,...
Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference
RANCHO CUCAMONGA, CA / ACCESSWIRE / August 28, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO,...
Breakthrough Technology Proves Rapid Relief of Depression With Non-Invasive Brain Stimulation
MINERAL WELLS, TX / ACCESSWIRE / August 28, 2024 / Depression, a debilitating disorder affecting millions worldwide, may soon be...
CORRECTING and REPLACING OMNY Health Launches Dynamic GLP-1 Network of 600,000+ Patients to Fuel Clinical Research on Its Use
New Studies on the Use of These Medications in Adult and Pediatric Populations are Supported by the Data NetworkATLANTA--(BUSINESS WIRE)--Please...
EydisBio Awarded $2.6 Million Grant to Advance TAK1 Inhibitor Program for Systemic Sclerosis
DURHAM, N.C., Aug. 28, 2024 /PRNewswire/ -- EydisBio, an early-stage pharmaceutical company leveraging a novel approach to treating various autoimmune...
Metabolon and the Scottish Early Rheumatoid Arthritis (SERA) Study Announce Partnership to Leverage Metabolomics Data to Better Understand the Molecular Mechanisms of Rheumatoid Arthritis
Partnership seeks to identify rheumatoid arthritis biomarkers to improve understanding of disease risk, progression, and treatment responses MORRISVILLE, N.C. and...
NurExone Reports Second Quarter 2024 Financial Results and Provides Corporate Update
TORONTO and HAIFA, Israel, Aug. 28, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (the...
Optimi Health & ATMA Receive No Objection Letter from Health Canada for Phase 2 Clinical Trial
Trial to study Major Depressive Disorder using Optimi's GMP natural psilocybin capsules in conjunction with therapyVancouver, British Columbia--(Newsfile Corp. -...